alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
**Avis juridique important**

*|*

# 31995R2268

**Commission Regulation (EC) No 2268/95 of 27 September 1995 concerning the second list of priority substances as foreseen under Council Regulation (EEC) No 793/93***Official Journal L 231 , 28/09/1995 P. 0018 - 0019*

COMMISSION REGULATION (EC) No 2268/95 of 27 September 1995 concerning the second list of priority  substances as foreseen under Council Regulation (EEC) No 793/93

THE COMMISSION OF  THE EUROPEAN COMMUNITIES,

 Having regard to the Treaty establishing the European Community,

 Having regard to Council Regulation (EEC) No 793/93 of 23 March 1993 on the evaluation and control  of the risks of existing substances  (1), and in particular Articles 8 and 10 thereof,

 Whereas Regulation (EEC) No 793/93 envisages a system of evaluation and control of the risks of  existing substances and whereas in order to undertake the risk evaluation of such substances, it is  appropriate to identify priority substances requiring attention;

 Whereas in consequence, Article 8 of Regulation (EEC) No 793/93 requires that the Commission shall  draw up a list of priority substances and whereas Article 8 further indicates the factors which  shall be taken into account in drawing up the said list;

 Whereas Article 10 of Regulation (EEC) No 793/93 foresees that for each substance on the priority  lists a Member State shall be given responsibility for its evaluation and whereas the allocation of  substances shall ensure a fair sharing of the burden between Member States;

 Whereas a first priority list has been adopted by Commission Regulation (EC) No 1179/94  (2);

 Whereas, the provisions of this Regulation are in accordance with the opinion of the Committee  established pursuant to Article 15 of Regulation (EEC) No 793/93,

 HAS ADOPTED THIS REGULATION:

Article 1 

Priority list 

1.  The second list of priority substances is hereby  established and is set out in the Annex to this Regulation.

 2.  For each substance on the priority list, the Member State which shall be responsible for its  evaluation is hereby designated and is indicated in the Annex to this Regulation.

Article 2 

This Regulation shall enter into force on the 20th day following its publication in the  Official Journal of the European Communities.

This Regulation shall be binding in its entirety and directly applicable in all  Member States.

 Done at Brussels, 27 September 1995.

 For the Commission Ritt BJERREGAARD Member of the Commission  

ANNEX 

>TABLE>
**Exhibit 31.1**

**CertificatePursuant to Rule 15d-14 under the Securities Exchange Act of 1934**

I, Paul Block, certify that:

1. I have reviewed this quarterly report of MerisantCompany (the “registrant”);

2. Based on my knowledge, this report does not containany untrue statement of a material fact or omit to state a material factnecessary to make the statements made, in light of the circumstances underwhich such statements were made, not misleading with respect to the periodcovered by this report;

3. Based on my knowledge, the financial statements,and other financial information included in this report, fairly present in allmaterial respects the financial condition, results of operations and cash flowsof the registrant as of, and for, the periods presented in this report;

4. Theregistrant’s other certifying officer and I are responsible for establishingand maintaining disclosure controls and procedures (as defined in Exchange ActRules 13a-15(e) and 15d-15(e)) for the registrant andhave:

(a)                                  Designedsuch disclosure controls and procedures, or caused such disclosure controls andprocedures to be designed under our supervision, to ensure that materialinformation relating to the registrant, including its consolidatedsubsidiaries, is made known to us by others within those entities, particularlyduring the period in which this report is being prepared;

(b)                                 Evaluatedthe effectiveness of the registrant’s disclosure controls and procedures andpresented in this report our conclusions about the effectiveness of thedisclosure controls and procedures, as of the end of the period covered by thisreport based on such evaluation; and

(c)                                  Disclosedin this report any change in the registrant’s internal control over financialreporting that occurred during the registrant’s most recent fiscal quarter (theregistrant’s fourth fiscal quarter in the case of an annual report) that hasmaterially affected, or is reasonably likely to materially affect, theregistrant’s internal control over financial reporting; and

5.             The registrant’s other certifyingofficer and I have disclosed, based on our most recent evaluation of internalcontrol over financial reporting, to the registrant’s auditors and the auditcommittee of the registrant’s board of directors (or persons performing theequivalent functions):

(a)                                  Allsignificant deficiencies and material weaknesses in the design or operation ofinternal control over financial reporting which are reasonably likely toadversely affect the registrant’s ability to record, process, summarize andreport financial information; and

(b)                                 Anyfraud, whether or not material, that involves management or other employees whohave a significant role in the registrant’s internal control over financialreporting.

Date: November 13, 2006
|        |   | /s/ Paul Block                 |
|--------|--------|--------------------------------|
|   |   | Name: Paul Block               |
|   |   | Title: Chief Executive Officer |

 

----
xml version="1.0" encoding="UTF-8"?


C\_2018187EN.01000601.xml


| | | | |
| --- | --- | --- | --- |
| 1.6.2018 | EN | Official Journal of the European Union | C 187/6 |

---

Prior notification of a concentration

(Case M.8889 — Teva/PGT OTC Assets)

(Text with EEA relevance)

(2018/C 187/06)

1.

On 25 May 2018, the Commission received notification of a proposed concentration pursuant to Article 4 of Council Regulation (EC) No 139/2004 [(1)](#ntr1-C_2018187EN.01000601-E0001).

This notification concerns the following undertakings:

| | |
| --- | --- |
| — | Teva Pharmaceuticals Industries Ltd (‘Teva’, Israel), |

| | |
| --- | --- |
| — | Part of the over-the-counter (‘OTC’) business that Teva previously contributed to a joint venture (‘PGT’) controlled by The Procter & Gamble Company (‘P&G’, United States) (‘Target’). |

Teva acquires within the meaning of Article 3(1)(b) of the Merger Regulation sole control of the Target.

The concentration is accomplished by way of contract or any other means.

2.

The business activities of the undertakings concerned are:

—   for Teva: global pharmaceutical company involved in the development, production and marketing of generic and proprietary pharmaceutical products, as well as biopharmaceuticals and active pharmaceutical ingredients,

—   for Target: number of OTC pharmaceutical products previously contributed by Teva to PGT, including marginal sales in cosmetic products, medical devices, food supplements and general articles.

3.

On preliminary examination, the Commission finds that the notified transaction could fall within the scope of the Merger Regulation. However, the final decision on this point is reserved.

4.

The Commission invites interested third parties to submit their possible observations on the proposed operation to the Commission.

Observations must reach the Commission not later than 10 days following the date of this publication. The following reference should always be specified:

M.8889 — Teva/PGT OTC Assets

Observations can be sent to the Commission by email, by fax, or by post. Please use the contact details below:

| |
| --- |
| Email: COMP-MERGER-REGISTRY@ec.europa.eu |
| Fax +32 22964301 |
| Postal address: |
| European Commission |
| Directorate-General for Competition |
| Merger Registry |
| 1049 Bruxelles/Brussel |
| BELGIQUE/BELGIË |

---

[(1)](#ntc1-C_2018187EN.01000601-E0001)  [OJ L 24, 29.1.2004, p. 1](http://publications.europa.eu/resource/oj/JOL_2004_024_R_TOC) (the ‘Merger Regulation’).

---
To the Shareholders and Board of Directors of
Smith Barney World Funds, Inc.:

In planning and performing our audit of the financial statements 
of Smith Barney World Funds, Inc. (the "Funds") consisting of 
Global Government Bond Portfolio, International Equity Portfolio, 
International Balanced Portfolio, Emerging Markets Portfolio, 
European Portfolio and Pacific Portfolio for the year ended 
October 31, 1998, we considered its internal control, including 
control activities for safeguarding securities, in order to 
determine our auditing procedures for the purpose of expressing 
our opinion on the financial statements and to comply with the 
requirements of Form N-SAR, not to provide assurance on the 
internal control.

The management of the Funds is responsible for establishing and 
maintaining internal control.  In fulfilling this responsibility, 
estimates and judgments by management are required to assess the 
expected benefits and related costs of controls.  Generally, 
controls that are relevant to an audit pertain to the entity's 
objective of preparing financial statements for external purposes 
that are fairly presented in conformity with generally accepted 
accounting principles. Those controls include the safeguarding of 
assets against unauthorized acquisition, use, or disposition. 

Because of inherent limitations in internal control, error or 
fraud may occur and not be detected.  Also, projection of any 
evaluation of internal control to future periods is subject to 
the risk that it may become inadequate because of changes in 
conditions or that the effectiveness of the design and operation 
may deteriorate.

Our consideration of the internal control would not necessarily 
disclose all matters in internal control that might be material 
weaknesses under standards established by the American Institute 
of Certified Public Accountants.  A material weakness is a 
condition in which the design or operation of one or more of the 
internal control components does not reduce to a relatively low 
level the risk that misstatements caused by error or fraud in 
amounts that would be material in relation to the financial 
statements being audited may occur and not be detected within a 
timely period by employees in the normal course of performing 
their assigned functions.  However, we noted no matters involving 
internal control and its operation, including controls for 
safeguarding securities that we consider to be material 
weaknesses as defined above. 

This report is intended solely for the information and use of 
management, the Board of Directors of the Funds, and the 
Securities and Exchange Commission.



December 18, 1998
GREENWICH STREET SERIES FUND
on behalf of the
Diversified Strategic Income Portfolio 

Supplement dated July 27, 1998
to the Prospectus dated April 30, 1998

	The following information supplements, and to the extent 
inconsistent therewith supersedes, the information set forth in the 
Prospectus under "Additional Investments."

Real Estate Investment Trusts

The Diversified Strategic Income Portfolio may invest in real 
estate investment trusts ("REITs").  REITs are entities which 
either own properties or make construction or mortgage loans.  
Equity trusts own real estate directly and the value of, and 
income earned by, the trust depends upon the income of the 
underlying properties and the rental income they earn.  Equity 
trusts may also include operating or finance companies.  Equity 
trusts can also realize capital gains by selling properties 
that have appreciated in value.  A mortgage trust can make 
construction, development or long-term mortgage loans, and are 
sensitive to the credit quality of the borrower.  Mortgage 
trusts derive their income from interest payments.  Hybrid 
trusts combine the characteristics of both equity and mortgage 
trusts, generally by holding both ownership interests and 
mortgage interests in real estate.  The value of securities 
issued by REITs are affected by tax and regulatory requirements 
and by perceptions of management skill.  They are also subject 
to heavy cash flow dependency, defaults by borrowers or 
tenants, self-liquidation, the possibility of failing to 
qualify for tax-free status under the Internal Revenue Code of 
1986, as amended, and failing to maintain exemption from the 
Investment Company Act of 1940, as amended.









FD 01527

U:\legal\funds\$ssf\1998\secdocs\798stk5
To the Shareholders and Board of Directors of
Greenwich Street California Municipal Fund Inc.:

In planning and performing our audit of the financial statements
of Greenwich Street California Municipal Fund Inc. (the "Fund")
for the year ended August 31, 1997, we considered its internal
control structure, including procedures for safeguarding
securities, in order to determine our auditing procedures for the
purpose of expressing our opinion on the financial statements and
to comply with the requirements of Form N-SAR, not to provide
assurance on the internal control structure.

The management of the Fund is responsible for establishing and
maintaining an internal control structure.  In fulfilling this
responsibility, estimates and judgments by management are
required to assess the expected benefits and related costs of
internal control structure policies and procedures.  Two of the
objectives of an internal control structure are to provide
management with reasonable, but not absolute, assurance that
assets are safeguarded against loss from unauthorized use or
disposition and that transactions are executed in accordance with
management's authorization and recorded properly to permit
preparation of financial statements in conformity with generally
accepted accounting principles.

Because of inherent limitations in any internal control
structure, errors or irregularities may occur and not be
detected.  Also, projection of any evaluation of the structure to
future periods is subject to the risk that it may become
inadequate because of changes in conditions or that the
effectiveness of the design and operation may deteriorate.

Our consideration of the internal control structure would not
necessarily disclose all matters in the internal control
structure that might be material weaknesses under standards
established by the American Institute of Certified Public
Accountants.  A material weakness is a condition in which the
design or operation of the specific internal control structure
elements does not reduce to a relatively low level the risk that
errors or irregularities in amounts that would be material in
relation to the financial statements being audited may occur and
not be detected within a timely period by employees in the normal
course of performing their assigned functions.  However, we noted
no matters involving the internal control structure, including
procedures for safeguarding securities, which we consider to be
material weaknesses as defined above as of August 31, 1997.

This report is intended solely for the information and use of
management and the Securities and Exchange Commission.




October 15, 1997
UNPUBLISHED

UNITED STATES COURT OF APPEALS

FOR THE FOURTH CIRCUIT

No. 01-6233

UNITED STATES OF AMERICA,

Plaintiff - Appellee,

versus

BERTRAND LEVON CURTIS, a/k/a X,

Defendant - Appellant.

Appeal from the United States District Court for the District of

Maryland, at Baltimore. Catherine C. Blake, District Judge. (CA01-127-CCB)

Submitted: March 13, 2001 Decided: April 23, 2001

Before WIDENER, NIEMEYER, and LUTTIG, Circuit Judges.

Dismissed by unpublished per curiam opinion.

Bertrand Levon Curtis, Appellant Pro Se. Lynne Ann Battaglia,

Christine Manuelian, OFFICE OF THE UNITED STATES ATTORNEY, Baltimore, Maryland, for Appellee.

Unpublished opinions are not binding precedent in this circuit.

See Local Rule 36(c).
2

PER CURIAM:

Bertrand Leon Curtis seeks to appeal the district court’s

order denying his motion filed under 28 U.S.C.A. § 2255 (West Supp.

2000). Assuming Curtis’ claim is not procedurally defaulted, a

matter not addressed by the district court and one we do not decide, we have reviewed the record and the district court’s opinion

and find no reversible error. Accordingly, we deny a certificate

of appealability and dismiss the appeal. See United States v.

Curtis, No. CA-01-127-CCB (D. Md. Jan. 26, 2001). We dispense with

oral argument because the facts and legal contentions are adequately presented in the materials before the court and argument would

not aid the decisional process.

DISMISSED
FNU TANZIN, et al., Petitioners, v. Muhammed TANVIR, et al.

No. 19-71

Supreme Court of the United States.

January 13, 2020

Motion of petitioner to dispense with printing the joint appendix granted.
ENERGY HOLDINGS INTERNATIONAL, INC. 10-Q/A



EXHIBIT 32.2

CERTIFICATION PURSUANT
TO

18 U.S.C. SECTION
1350, AS ADOPTED PURSUANT TO

SECTION 906 OF THE
SARBANES-OXLEY ACT OF 2002



In connection with
the Quarterly Report of Energy Holdings International, Inc. (the "Company") on Form 10-Q/A for the quarterly period ended
September 30, 2014 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Jalal
Alghani, Director and Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant
to Section 906 of the Sarbanes-Oxley Act of 2002, that:



1.           The
Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and



2.           The
information contained in the Report fairly presents, in all material aspects, the financial condition and results of operations
of the Company.



Date:  February 2, 2015



|/s/ Jalal Alghani                   
|------------------------------------
|Jalal Alghani                       
|Director and Chief Financial Officer
|                                    
|
[Cite as Zanesville v. Rouse, 126 Ohio St.3d 1227, 2010-Ohio-3754.] 

THE CITY OF ZANESVILLE, APPELLANT, v. ROUSE, APPELLEE. 

[Cite as Zanesville v. Rouse, 126 Ohio St.3d 1227, 2010-Ohio-3754.] 

Motion for reconsideration granted in part, judgment reinstating the judgment of 

the trial court vacated, and cause remanded to the court of appeals.

(No. 2009-1282 — Submitted August 10, 2010 — Decided August 17, 2010.) 

APPEAL from the Court of Appeals for Muskingum County, 

No. CT08-0035, 2009-Ohio-2689. 

ON MOTION FOR RECONSIDERATION

__________________ 

{¶ 1} On May 26, 2010, the court reversed the judgment of the court of 

appeals in this case and reinstated the judgment of the trial court. Zanesville v. 

Rouse, 126 Ohio St.3d 1, 2010-Ohio-2218, 929 N.E.2d 1044. 

{¶ 2} Appellee filed a motion for reconsideration, arguing in part that the 

court of appeals did not consider several assignments of error raised by appellee. 

{¶ 3} The motion for reconsideration is granted to the following extent: 

The portion of the court’s May 26, 2010 judgment reinstating the judgment of the 

trial court is vacated, and the cause is remanded to the court of appeals for 

consideration of appellee’s assignments of error held to be moot below. 

 BROWN, C.J., and LUNDBERG STRATTON, O’CONNOR, O’DONNELL,

LANZINGER, and CUPP, JJ., concur. 

 PFEIFER, J., dissents. 

__________________ 

 Scott T. Hillis, Zanesville Law Director, and Susan E. Small, Assistant 

Law Director, for appellant. 

 Elizabeth N. Gaba and David T. Spencer, for appellee. 

______________________
<TABLE> <S> <C>

<ARTICLE> 6
<CIK> 0000919557
<NAME> MFS Total Return Portflio
<SERIES>
   <NUMBER>010
   <NAME>Travelers Series Fund Inc.

<S>                         <C>
<PERIOD-TYPE>              Year
<FISCAL-YEAR-END>                 Oct-31-2001
<PERIOD-END>                      Oct-31-2000
<INVESTMENTS-AT-COST>             650,972,426
<INVESTMENTS-AT-VALUE>            696,797,091
<RECEIVABLES>                      12,282,189
<ASSETS-OTHER>                        112,257
<OTHER-ITEMS-ASSETS>                        0
<TOTAL-ASSETS>                    709,191,537
<PAYABLE-FOR-SECURITIES>           11,431,834
<SENIOR-LONG-TERM-DEBT>                     0
<OTHER-ITEMS-LIABILITIES>             749,934
<TOTAL-LIABILITIES>                12,181,768
<SENIOR-EQUITY>                             0
<PAID-IN-CAPITAL-COMMON>          603,537,236
<SHARES-COMMON-STOCK>              40,607,925
<SHARES-COMMON-PRIOR>              38,345,904
<ACCUMULATED-NII-CURRENT>          21,793,821
<OVERDISTRIBUTION-NII>                      0
<ACCUMULATED-NET-GAINS>            25,830,761
<OVERDISTRIBUTION-GAINS>                    0
<ACCUM-APPREC-OR-DEPREC>           45,847,951
<NET-ASSETS>                      697,009,769
<DIVIDEND-INCOME>                   7,477,463
<INTEREST-INCOME>                  19,539,872
<OTHER-INCOME>                              0
<EXPENSES-NET>                      5,274,284
<NET-INVESTMENT-INCOME>            21,743,051
<REALIZED-GAINS-CURRENT>           26,277,888
<APPREC-INCREASE-CURRENT>          30,253,690
<NET-CHANGE-FROM-OPS>              78,274,629
<EQUALIZATION>                              0
<DISTRIBUTIONS-OF-INCOME>          17,520,200
<DISTRIBUTIONS-OF-GAINS>           21,749,058
<DISTRIBUTIONS-OTHER>                       0
<NUMBER-OF-SHARES-SOLD>             3,058,479
<NUMBER-OF-SHARES-REDEEMED>         3,292,914
<SHARES-REINVESTED>                 2,496,456
<NET-CHANGE-IN-ASSETS>             75,181,388
<ACCUMULATED-NII-PRIOR>            17,561,649
<ACCUMULATED-GAINS-PRIOR>          21,311,252
<OVERDISTRIB-NII-PRIOR>                     0
<OVERDIST-NET-GAINS-PRIOR>                  0
<GROSS-ADVISORY-FEES>               5,085,377
<INTEREST-EXPENSE>                          0
<GROSS-EXPENSE>                     5,274,284
<AVERAGE-NET-ASSETS>              632,366,232
<PER-SHARE-NAV-BEGIN>                  16.220
<PER-SHARE-NII>                         0.540
<PER-SHARE-GAIN-APPREC>                 1.430
<PER-SHARE-DIVIDEND>                    0.460
<PER-SHARE-DISTRIBUTIONS>               0.570
<RETURNS-OF-CAPITAL>                    0.000
<PER-SHARE-NAV-END>                    17.160
<EXPENSE-RATIO>                          0.83



</TABLE>
# Official Journal L 324/2009

| | ISSN 1725-2555
  doi:10.3000/17252555.L_2009.324.eng |
| --- | --- |
| Official Journal
  of the European Union | L 324 |
| | |
| English edition | Legislation | Volume 5210 December 2009 |

ISSN 1725-2555

doi:10.3000/17252555.L_2009.324.eng

Official Journal

of the European Union

L 324

English edition

Legislation

Volume 5210 December 2009

---

| Contents | | I   Acts adopted under the EC Treaty/Euratom Treaty whose publication is obligatory | page |
| --- | --- | --- | --- |
| | | REGULATIONS |
| | * | Regulation (EC) No 1185/2009 of the European Parliament and of the Council of 25 November 2009 concerning statistics on pesticides (1) | 1 |
| | * | Council Regulation (EC) No 1186/2009 of 16 November 2009 setting up a Community system of reliefs from customs duty | 23 |

Contents

I   Acts adopted under the EC Treaty/Euratom Treaty whose publication is obligatory

page

REGULATIONS

*

Regulation (EC) No 1185/2009 of the European Parliament and of the Council of 25 November 2009 concerning statistics on pesticides (1)

1

*

Council Regulation (EC) No 1186/2009 of 16 November 2009 setting up a Community system of reliefs from customs duty

23

| | |
| --- | --- |
| | (1)   Text with EEA relevance |

---

(1)   Text with EEA relevance

1

| EN | Acts whose titles are printed in light type are those relating to day-to-day management of agricultural matters, and are generally valid for a limited period.
  The titles of all other Acts are printed in bold type and preceded by an asterisk. |
| --- | --- |

EN

Acts whose titles are printed in light type are those relating to day-to-day management of agricultural matters, and are generally valid for a limited period.

The titles of all other Acts are printed in bold type and preceded by an asterisk.
Lahim KADRIA, Petitioner, v. William P. BARR, Attorney General.

No. 19-534

Supreme Court of the United States.

Jan. 27, 2020

Petition for writ of certiorari to the United States Court of Appeals for the Second Circuit denied.